| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $36.2M | +4.0% |
| SG&A Expense | $30.2M | -48.9% |
| Operating Income | -$66.3M | +29.3% |
| Pre-tax Income | -$56.8M | +39.7% |
| Income Tax | -$1.2M | +0.0% |
| Net Income | -$56.8M | +39.0% |
| EPS (Basic) | -$1.84 | +45.9% |
| EPS (Diluted) | -$1.84 | +45.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $142.1M | +6.4% |
| Current Assets | $146.1M | +6.4% |
| Total Assets | $170.0M | +3.7% |
| Current Liabilities | $17.9M | +71.9% |
| Total Liabilities | $19.1M | +54.6% |
| Stockholders' Equity | $150.9M | -0.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$50.1M | -9.4% |
| Investing Cash Flow | -$297K | +0.0% |
| Financing Cash Flow | $59.1M | -40.2% |